May 8, 2024 LOS ALTOS, Calif. — SightGlass Vision presented four studies at the Association for Research in Vision and Ophthalmology (ARVO)...
March 1, 2024 By Nabin Paudel, BOptom, PhD Myopia is a growing public health concern that will affect an estimated 4.7 billion...
February 14, 2024 LOS ALTOS, Calif. — SightGlass Vision’s Diffusion Optics Technology (DOT) spectacle lenses have received Breakthrough Device designation from the...
November 9, 2023 SYDNEY, Australia — The International Myopia Institute (IMI) has released its 2023 update for the Facts and Finding Infographic....
September 20, 2023 LOS ALTOS, Calif. — SightGlass Vision’s Diffusion Optics Technology (DOT) spectacle lenses are the subject of a recently released...
September 5, 2023 CHANGSHA, China — At the Congress of the Chinese Ophthalmological Society (CCOS) in Changsha, SightGlass Vision shared the four-year results...
October 25, 2022 LOS ALTOS, Calif. — New findings from SightGlass Vision’s three-year CYPRESS clinical trial have highlighted the efficacy of the...
June 23, 2022 PALO ALTO, Calif. — In analyzing two-year data from SightGlass Vision’s CYPRESS clinical trial, experts have learned that the...
March 24, 2022 PALO ALTO, Calif. — SightGlass Vision announced the appointment of three new leadership positions to its executive team. Andrew...